Description

Product Description

Carboplatin Injection is a research-grade chemotherapeutic agent formulated to deliver Carboplatin in a water-soluble, injectable solution suitable for laboratory and preclinical studies. As a second-generation platinum complex, Carboplatin has been engineered to provide comparable DNA crosslinking activity to cisplatin, while exhibiting improved solubility and reduced nephrotoxicity under controlled experimental conditions.

In laboratory research, Carboplatin Injection serves as a critical tool for understanding the cellular mechanisms of platinum-induced DNA damage, apoptosis, and cell cycle arrest. Its water-soluble formulation enables precise dosing in cell culture and animal models, facilitating the study of pharmacokinetics, pharmacodynamics, and combinatorial cytotoxic effects. Researchers often use Carboplatin Injection to evaluate cellular responses to DNA adduct formation, repair pathway activation, and apoptotic signaling, providing insights into chemotherapeutic resistance and efficacy.

Carboplatin Injection has been widely utilized in oncology research focusing on tumor biology, cell proliferation inhibition, and cytotoxic synergy with other chemotherapeutic agents. The formulation supports studies on platinum-induced DNA interstrand crosslinks and downstream effects on tumor suppressor genes and cell survival pathways. Additionally, its injectable format allows direct administration in preclinical animal studies, enabling researchers to simulate clinical-like pharmacological exposures while maintaining strict control over experimental variables.

This compound is provided as a high-purity, sterile solution suitable for research laboratories. It is intended exclusively for experimental applications and preclinical investigations, not for human or veterinary therapeutic use. Researchers must adhere to institutional biosafety and chemical safety protocols when handling Carboplatin Injection.

Product Specifications

Mechanism of Action

Carboplatin Injection functions as a platinum-based DNA-damaging agent. Its primary mechanism involves the formation of covalent DNA adducts, predominantly interstrand and intrastrand crosslinks, which disrupt the DNA double helix and inhibit replication and transcription processes. This damage triggers the activation of multiple cellular pathways, including DNA damage response (DDR), cell cycle checkpoint activation, and apoptosis.

1. DNA Crosslink Formation
   Carboplatin coordinates with nucleophilic sites on guanine bases, forming platinum-DNA adducts. This crosslinking prevents strand separation, directly inhibiting replication and transcription in proliferating cells.

2. Activation of DNA Damage Response
   DNA adducts induced by Carboplatin stimulate the phosphorylation of key DDR proteins such as ATR, ATM, and p53, leading to cell cycle arrest at G2/M phase and facilitating DNA repair or apoptosis in irreparably damaged cells.

3. Apoptosis Induction
   Persistent DNA crosslinks lead to the activation of intrinsic apoptotic pathways. Cytochrome c release, caspase-9 activation, and subsequent caspase-3/7 cleavage are observed in preclinical studies, confirming the cytotoxic effects of Carboplatin at the cellular level.

4. Comparative Cytotoxic Profile
   In laboratory models, Carboplatin exhibits reduced nephrotoxicity compared to cisplatin while maintaining comparable anticancer efficacy, allowing safer preclinical administration in in vivo experiments.

5. Synergistic Research Applications
   Carboplatin Injection is frequently studied in combination with other chemotherapeutic agents, targeted peptides, or small molecules to evaluate synergistic cytotoxicity, resistance mechanisms, and DNA repair modulation.

6. Influence on Tumor Suppressor Pathways
   Research indicates Carboplatin treatment affects tumor suppressor genes such as p53 and BRCA1/2, providing insight into platinum resistance and DNA repair deficiency models.

   

Side Effects

In preclinical research, Carboplatin Injection has shown predictable cytotoxicity corresponding to dose and exposure. Laboratory models have demonstrated typical platinum-induced effects including DNA damage, cell cycle arrest, and apoptosis.

Potential experimental side effects include:

• Dose-dependent cytotoxicity in rapidly dividing cells.

• Activation of DNA damage response pathways leading to cell death.

• Potential oxidative stress induction in sensitive cell lines.

Researchers should consider solvent composition, dosing regimen, and experimental model when interpreting results. Use of protective equipment and biosafety protocols is essential to minimize exposure risks. Carboplatin Injection is not intended for human or veterinary therapeutic use and must only be employed in controlled research or preclinical studies.

Keywords

Carboplatin Injection, platinum-based chemotherapeutic, DNA crosslinking, cytotoxicity research, tumor biology, factory peptide supplier, research peptide manufacturer, bulk peptide powder, OEM peptide production, China peptide factory, high purity, preclinical studies

Shipping Guarantee

All Carboplatin Injection shipments are handled using validated cold-chain logistics to preserve compound integrity. Each package is sealed in moisture-proof containers with secondary protective wrapping and continuous temperature monitoring. Products are shipped via express international couriers with full tracking and insurance coverage.

Trade Assurance

We Carboplatin Injection ensure product authenticity, verified ≥99% purity, and compliance with analytical standards (HPLC, MS, and NMR). Each batch is supplied with a Certificate of Analysis (CoA). Our trade assurance policy guarantees replacement or refund for any deviation from listed specifications.

Payment Support

We Carboplatin Injection provide flexible and secure global payment options to support international research transactions. Accepted payment methods include PayPal, major credit cards (Visa, MasterCard, American Express), telegraphic transfer (T/T), and cryptocurrencies (USDT, Bitcoin, Ethereum). All transactions are protected by industry-standard encryption and verified payment gateways to ensure confidentiality and fund security.

Disclaimer

All Carboplatin Injection products listed are intended for laboratory and preclinical research use only and not for human or veterinary use. They are not drugs, medical devices, or diagnostics and should not be administered to humans or animals. Researchers must handle all materials in accordance with institutional biosafety and chemical safety guidelines. The information provided is for scientific reference only and does not imply therapeutic efficacy, safety, or regulatory approval.